我们改变生活
推动体系变革
在过去5年中，世界卫生组织发布的新增指南中有75%至少引用了1篇Cochrane系统综述。了解我们的影响。
我们的证据
值得信赖
科学家、政策制定者和决策者向我们寻求可靠的证据。了解我们的证据为什么值得信赖。
我们在全球范围内
开展合作
我们通过与各领域专家和公众广泛合作，产出卓越的证据。加入我们。
News
Common gout drug may reduce risk of heart attack and stroke
12 十一月 2025
A widely-used, inexpensive gout drug could reduce heart attacks and strokes in people with cardiovascular disease, according to a new Cochrane review.
Setting the standards for responsible AI use in evidence synthesis
11 十一月 2025
Cochrane, the Campbell Collaboration, JBI, and the Collaboration for Environmental Evidence have published a joint position statement on the responsible use of artificial intelligence (AI) in evidence synthesis.
GLP-1 drugs effective for weight loss, but more independent studies needed
30 十月 2025
Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions.
What is Cochrane doing to strengthen research integrity?
29 十月 2025
We continue to lead the field in trustworthiness and transparency by evolving our practices to address the most pressing challenges in research integrity and publishing ethics, and to respond to rapid advances in technology. Here is a wrap up of recent developments in these areas.
是什么让Cochrane与众不同？
了解我们独特的健康相关证据、我们的工作方式以及我们所带来的改变。
需要定制的证据服务？
我们为任何使用健康证据的人提供工具、数据和定制服务。
撰写Cochrane系统综述？
需要撰写系统综述的指导？有兴趣成为Cochrane作者？
